SHARMEH P/E Ratio
Current P/E Ratio
25.33
High Valuation
High - Growth expectations or overvalued
SHARMEH (SHARMEH) P/E ratio is 25.33 (High), EPS (TTM) ₹3.78, current price ₹100.90 on BSE — High - Growth expectations or overvalued. Read SHARMEH dividend track record for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
25.33
Current Price
₹100.90
EPS (TTM)
₹3.78
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
112.88
Sector Median
41.37
Sector Rank
#11 of 57
Sector Percentile
19.3%
SHARMEH P/E Ratio — Valuation Signal & Historical Context
SHARMEH P/E 25.33 — signal: Overvalued. See SHARMEH P/B valuation to compare market price against book value per share.
- Stock appears overvalued with PE of 25.33, suggesting caution for new investments
- Trading at discount to sector average PE of 112.88
SHARMEH vs Healthcare Services Peers — P/E Ratio Comparison
SHARMEH P/E 25.33 vs Healthcare Services average 112.88, median 41.37 — range 8.87–3045.0.
Sector Average
112.88
Sector Median
41.37
Lowest P/E
8.87
Highest P/E
3045.0
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.87 | ₹165 | Low |
| Abate AS Industries | ABATEAS | 12.29 | ₹153 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.5 | ₹18 | Low |
| Deccan Health Care | DECCAN | 12.92 | ₹31 | Low |
| Shanmuga Hospital | SHANMUGA | 14.28 | ₹59 | Low |
| Krsnaa Diagnostics | KRSNAA | 17.41 | ₹1,792 | Moderate |
| Sangani Hospitals | SANGANI | 17.61 | ₹59 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.64 | ₹1,178 | Moderate |
| Invicta Diagnostic | INVICTA | 17.85 | ₹85 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.9 | ₹1,088 | Moderate |